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Introduction 1
Multidrug resistance (MDR) efflux pumps play a key role in antimicrobial resistance through 2 the active transport of antimicrobial agents outside the cell. Depending on their basal level of 3 expression, they can contribute to the intrinsic resistance to different compounds displayed by 4 bacterial pathogens. In addition, the overexpression of MDR efflux pumps also leads to high 5 levels of resistance to clinically useful antibiotics (1). The resistance nodulation division 6 (RND) MDR family is the best characterized one. Members of this family are present just in 7
Gram-negative bacteria, being associated with clinically relevant antimicrobial resistance (2, 8 3). While RND systems are usually expressed at very low level (if any) under regular 9 growing conditions, a diversity of complex pathways is involved in the regulation of their 10 expression, which may require the participation of several global and local transcriptional 11 regulators belonging to different families, including TetR, LysR or two-component systems 12 (TCS) (4). 13
Stenotrophomonas maltophilia, a relevant emerging MDR opportunistic pathogen, exhibits 14 low susceptibility to a wide range of antibiotics due the presence of several resistance 15 mechanisms encoded in its genome, including eight MDR efflux pumps belonging to the 16 RND family (5-7). S maltophilia RND efflux pumps exhibit different patterns of regulation, 17 which makes this organism a suitable model for the investigation of these systems. For 18 instance, the expression of smeYZ efflux pump is linked to the TCS SmeRySy (8), and 19 smeVWX expression is regulated by the LysR-type regulator SmeRv (9). In addition, whereas 20 smeYZ is constitutively expressed at a significant level, hence contributing to intrinsic 21 resistance to aminoglycosides (10, 11) , smeVWX expression level is low and resistance is 22 only achieved through mutations in its regulator, leading to the overexpression of the efflux 23 pump (12) . 24 5 It is important to recall that overexpression of RND efflux pumps is not always associated 1 with genetic changes. Indeed, efflux pumps are expected to be expressed, when needed, in 2 response to specific signals/cues (2). In this respect, some situations can lead bacteria to 3 become transiently resistant, such as the presence of compounds that act as effectors, 4 triggering the expression of these MDR systems and displaying a phenotype of transient 5 resistance (13, 14) . These situations depend on the regulatory network of the RND efflux 6 pumps, including local and global regulators. Most of the RND effectors have been 7 discovered through the study of specific physiological processes wherein efflux pumps 8 participate, such as the colonization of particular niches, the extrusion of a particular toxic 9 compound or the characterization of specific regulators (15) (16) (17) . Besides the assigned specific 10 function of RND efflux pumps, these systems are in occasions considered stress defense 11 determinants (e.g. oxidative and nitrosative stress), acting as scape valves for the 12 accumulation of toxic compounds or stress by-products (18) . 13 RND efflux pumps are known to extrude a wide range of structurally different compounds, 14 some of which are usually well-characterized, especially when they are clinically relevant 15 antimicrobials (19) . However, less is known about the efflux pump effectors. Knowing the set 16 of RND inducer molecules could be helpful for characterizing MDR efflux systems, getting 17
understanding on their potential functional and ecological roles, as well as for detecting 18 possible situations of phenotypic induction of resistance in vivo that would not be detected by 19 classical laboratory susceptibility tests. In this study, we have performed a systematic 20 (see Materials and Methods) to obtain a proxy value of the transcription activity. Briefly, the 1 production of fluorescence was quantified for each curve giving rise to the maximum specific 2 rate of fluorescence production parameter (i.e. µ EM7 µ YZ or µ VWX for each compound and 3 concentration). Then, all values representing P YZ or P VWX transcription activity were 4 normalized using the constitutive fluorescence given by the P EM7 as control. This step is 5 required in order to avoid any effect of the toxic compound on the fluorescence signal, which 6 may be caused by itself or by its action on the growth rate, being inversely related to the 7 fluorescence signal (32). Finally, the µ VWX /µ EM7 and µ YZ /µ EM7 values for each compound and 8 concentration were used to represent the normalized transcription activity of P VWX and P YZ , 9 respectively. 10 To stablish a threshold value that enables to define overexpression, all efflux pump 11 transcription proxies' values were depicted in a box plot ( Figure 1 ). In this way, a threshold 12 of µ VWX /µ EM7 = 0.14 and µ YZ /µ EM7 = 0.89 were set to define those situations where smeVWX 13 and smeYZ were considered to be overexpressed. All the compounds and concentrations that 14 gave rise to both efflux pumps overexpression are listed in Table 2 . In the case of the 15 SmeVWX efflux pump, 23 compounds and 34 concentrations were found to exceed the 16 threshold, while 22 compounds and 39 concentrations were above the set threshold in the 17 case of the SmeYZ efflux pump. For instance, sodium selenite and 5-chloro-7-iodo-8-18 hydroxyquinoline caused the overexpression of smeVWX in the four tested concentrations, 19 and the same happens for smeYZ with protamine sulfate and 5-fluorootic acid. In the case of 20 18 compounds, only the maximum tested concentration led to the efflux pump 21
overexpression. 22
Confirmation of the increased expression of smeVWX and smeYZ in the presence of 23 potential inducers 24 9 Among those Biolog compounds that were able to produce an increase in the YFP levels for 1 each of the studied efflux pumps, we selected some of those for which the induction was 2 higher in order to validate the results. We selected as possible inducers of smeVWX 3 iodoacetate, clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) and sodium selenite; for 4 potential smeYZ inducers, we selected boric acid, chloramphenicol, erythromycin and 5 lincomycin. Since the quantity of each compound present in the Biolog plates is not available 6 for users, we first determined the MIC in order to know the concentrations to be used in the 7 following experiments. These concentrations were: iodoacetate, 1 mM; clioquinol, 0.065 8 mM; sodium selenite, ≥ 200 mM; boric acid, 25 mM; erythromycin, 256 µg/ml; 9 chloramphenicol, 4 µg/ml; lincomycin, 4096 µg/ml. Then, we selected three concentrations 10 below the MIC value for each compound in order to perform the induction assay. 11
To carry out the experiment, the reporter strains PBT02 (P VWX ) and PBT10 (P YZ ) were 12 incubated with their respective putative inducers for 20 h. The PBT03 (P EM7 ) strain was 13 incubated with all the compounds as a fluorescence control. In Fig. 2 , the YFP values and 14 growth given by the PBT02 and PBT10 strains are shown, using the concentration for which 15 the highest induction was obtained and bacterial growth was less compromised in each case: 16 0.5 mM sodium selenite, 78 µM clioquinol, 0.5 mM iodoacetate, 6.25 mM boric acid, 8 17 µg/ml erythromycin, 1 µg/ml chloramphenicol, and 128 µg/ml lincomycin. In agreement with 18 the Biolog data, iodoacetate, clioquinol and sodium selenite are able to increase the YFP 19 production through the induction of the smeVWX promoter in the PBT02 strain, in 20 comparison with the fluorescence observed in control medium without inducer ( Figure 2A) ; 21 while erythromycin, boric acid, chloramphenicol and lincomycin increase the YFP 22 production through the induction of the smeYZ promoter in the PBT10 strain, when compared 23 with the strain growing without these compounds ( Figure 2B ). PBT03 did not show any 24 difference in YFP production when incubated with the different compounds or without them 25 10 ( Figure 2C ). These results show that the observed fluorescence increment for both reporter 1 strains PBT02 and PBT10 when growing in the presence of the tested putative inducers is due 2 to the induction of the promoters of the tested efflux pumps and not an indirect effect of the 3 compounds themselves. 4
Single-cell analysis of the induction of the expression of MDR efflux pumps 5
In order to examine the effect of induction on the activity of smeVWX and smeYZ promoters 6 at single-cell level, we measured the YFP values by flow cytometry given by the two reporter 7 strains PBT02 and PBT10 after 90 min of incubation with their respective inducers when 8 cells reached exponential growth phase (OD 600 ≈ 0.6) ( Figure 3 ). This methodology lessens 9 any time-dependent interference with the fluorescence signal, such as the bacterial growth 10 phase or compound degradation. PBT03 was also treated with all the set of compounds as a 11 control ( Figure 3C and 3D). As shown in Fig. 3A , the bacterial populations of PBT02 strain 12 incubated with clioquinol, iodoacetate or sodium selenite present a higher smeVWX 13 expression than the untreated population. The same results are obtained when the PBT10 14 strain is incubated with boric acid, erythromycin, chloramphenicol or lincomycin, showing 15 these compounds to induce smeYZ expression ( Figure 3B ). For all the compounds, a normal 16 distribution of the level of expression was seen in the population, indicating that all cells 17
presented an increased expression of the corresponding efflux pump in presence of the 18 inducers. In addition, the expression levels correspond with those obtained in the above 19 growing curves, confirming that induction of efflux pumps promoters is produced at mid-20 exponential growth phase. 21
Analysis of the expression of efflux pumps in the presence of inducers at mRNA level. 22
For further confirmation of the results, the mRNA levels of smeV and smeY were quantified 23 by real-time RT-PCR in the presence of the different inducer compounds. As shown in Fig.  24 4A, smeV gene expression is increased by 764, 4402 and 8972-fold in the presence of 1 clioquinol, iodoacetate and sodium selenite, respectively, in comparison with the level given 2 by the efflux pump basal expression. The same effect is observed in Fig. 4B , where smeY 3 gene expression is increased by 6, 47, 71 and 102-fold in the presence of boric acid, 4 chloramphenicol, erythromycin and lincomycin, respectively, when comparing with the smeY 5 basal expression level. The obtained results are in agreement with the previous YFP-based 6 obtained results, validating once again the PBT02 sensor strain as well as the new developed 7 PBT10 strain. These data allow us to confirm that the selected compounds from Biolog plates 8 clioquinol, iodoacetate and sodium selenite are smeVWX inducers, and boric acid and the 9 antibiotics chloramphenicol, erythromycin and lincomycin are able to trigger smeYZ 10 expression. 11 Deletion of either smeW or smeZ does not alter the susceptibility of S. maltophilia to 12 their corresponding inducers 13
Since new inducer molecules (all of them with antimicrobial properties) of both SmeVWX 14 and SmeYZ multidrug efflux pumps have been identified, we wanted to elucidate whether 15 these compounds were also substrates of their respective efflux pumps. To test this 16 hypothesis, we used the MBS704 (∆smeW) strain (30) and we constructed a D457-derived 17 mutant with a partial deletion in the smeZ gene (PBT100 strain). In order to see whether or 18 not the lack of SmeVWX changed S. maltophilia susceptibility to its potential inducers, D457 19 and MBS704 (∆smeW) strains were grown for 20 h at 37 °C in the presence of clioquinol (78 20 µM), iodoacetate (0.5 mM) or sodium selenite (0.5 mM) and OD 600 was recorded every 10 21 min. The same experiment was performed for smeYZ inducers, growing D457 and PBT100 22 (∆smeZ) strains in the presence of boric acid (6.25 mM), chloramphenicol (1 µg/ml), 23 erythromycin (8 µg/ml) or lincomycin (128 µg/ml). If these compounds are being extruded 24 through the efflux pumps, it is expected that both smeW and smeZ-defective mutants have a 25 deficiency in their growth due to the toxicity of the different compounds. As shown in Fig. 5 , 1 no relevant differences are observed in the growth between the wild-type and the efflux 2 pump-defective strains in the presence of the different inducer compounds at the tested 3 concentrations. It is generally assumed that an efflux pump inducer molecules are also 4 extruded by the efflux system; the efflux pump hence confers resistance to such effectors if 5 they are toxic (33-36). However, the data obtained in this work support that efflux pumps do 6 not always confer resistance to their inducers, maybe because these compounds are not 7 substrates of the efflux pumps they induce. 8
The overexpression of MDR efflux pumps promote transient resistance to antibiotics 9
It is known that overexpression of smeVWX contributes to the acquired resistance to 10 chloramphenicol and quinolones of S. maltophilia (9), while SmeYZ is able to extrude 11 aminoglycosides, contributing to their intrinsic resistance (10, 11). Since new inducer 12 compounds have been identified for both RND efflux pumps, we wondered whether the 13 susceptibility of S. maltophilia would be altered in the presence of these putative effectors, 14 affecting then S. maltophilia transient resistance to the known antibiotic substrates of these 15
MDR determinants. 16
In order to test the contribution of the SmeVWX efflux pump to transient resistance, growth 17 curves were performed in the presence and in the absence of ofloxacin, and with or without 18 sodium selenite, using both the wild-type D457 strain and the ∆smeW deletion mutant 19 MBS704. As shown in Fig. 6A and 6B, sodium selenite, at the tested concentration, does not 20 compromise the growth of both strains significantly, whereas ofloxacin impairs the growth of 21 both D457 and MBS704. However, the combination of ofloxacin together with the smeVWX 22 inducer sodium selenite does not impede D457 growth. With the aim of assessing whether 23
SmeYZ may contribute to transient resistance when growing in the presence of potential 24 effectors, the same experiment was performed with both D457 and PBT100 (∆smeZ) in the 25 13 presence or absence of the efflux pump substrate amikacin, and with or without the inducer 1 lincomycin. As shown in Fig. 6C and 6D, lincomycin slightly reduces growth in both strains 2 due to its toxic effect. At the tested concentration of amikacin, the growth is compromised for 3 both strains; however, the presence of lincomycin diminishes the amikacin inhibitory effect. 4
These data suggest that both multidrug efflux pumps are involved in transient resistance to 5 antibiotics when inducers are present, since sodium selenite and lincomycin are able to 6 induce smeVWX and smeYZ, respectively, changing D457 susceptibility to their antibiotic 7 substrates. 8
Discussion 9
MDR efflux pumps expression is controlled by transcriptional regulators that act at different 10 levels. In addition to the direct regulation carried out by these regulators, one important 11 aspect to take into account is the overexpression of MDR efflux pumps triggered by the 12 presence of inducer molecules in the medium (13, 37) . The conditions that lead to this 13 transient expression of efflux systems, which consequently could give rise to antibiotic 14 resistance induction, are not fully explored and their detection is usually difficult through the 15 use of classical susceptibility methods (13). In this study, we have developed a new 16 methodology for the systematic analysis and identification of MDR efflux pumps' inducers 17 by combining the Biolog phenotype microarray technology with the use of fluorescent 18
bioreporters. 19
With the aim of identifying conditions or compounds that would induce the expression of the 20 S. maltophilia SmeVWX and SmeYZ efflux pumps, YFP-based reporter strains were 21 developed. In a previous screening using the PBT02 (P VWX ) strain, we identified that vitamin 22 K 3 , among 30 tested compounds, was an inducer of the SmeVWX system (30). In the current 23 study, two new reporter strains were constructed. The PBT10 strain contains the YFP protein 24 under the control of SmeYZ efflux pump promoter and the PBT03 strain, developed as a 25 14 positive fluorescence control since harbors the YFP protein under the control of the EM7 1 constitutive promoter. Employing Biolog phenotype microarrays, approximately 40 2 compounds were selected as potential candidates for being smeVWX or smeYZ inducers. 3 Among all the potential inducer compounds derived from the Biolog data analysis, clioquinol 4 (5-chloro-7-iodo-8-hydroxyquinoline), iodoacetate, sodium selenite (smeVWX inducer 5 candidates), boric acid, chloramphenicol, erythromycin and lincomycin (smeYZ inducer 6 candidates), were selected for further analysis. The fluorescence data obtained through the 7 use of Biolog plates were confirmed testing cognate concentrations of the selected agents. 8
The observed induction for both RND efflux pumps was also confirmed by flow cytometry at 9 mid-exponential growth phase after 90 min treatment with the corresponding compounds and 10 by RT-PCR under the same conditions, obtaining similar fold change results in the expression 11 level than those given by the flow cytometry assay. Hence, the Biolog technology has 12 allowed us to successfully identify a set of inducer molecules, being extended for this 13 purpose to other microbial systems.(38) 14 MDR efflux pumps, besides antibiotic resistance, contribute to different aspects of bacterial 15 physiology, including bacterial interaction with hosts (human, animals and plants) or 16 detoxification of cellular toxic metabolites (39). MDR efflux pumps can also take part of 17 general mechanisms of response to cellular stress that contribute to ameliorate the adverse 18 effects caused by stressors agents or stress by-products (e.g. oxidative stress or envelope 19 stress) (18, 40) . We hypothesize that when MDR efflux systems are participating in this 20 global cellular stress response, a general common inducer mechanism of stress could be 21 identified through the analysis of their inducer compounds, despite their structural diversity. 22
As described in this work, clioquinol, iodoacetate and sodium selenite have been identified as 23 smeVWX inducers, in addition to the previously described vitamin K 3 (30). Although 24 clioquinol, sodium selenite and vitamin K 3 are known to generate oxidative stress (41-44), we 25 15 determined in our previous work that tert-butyl hydroperoxide, another oxidative stress agent, 1 was not able to induce smeVWX (30). In addition, iodoacetate is not related to oxidative stress 2 production (45). However, all of the identified inducer compounds are associated with thiol-3 reactivity. For instance, iodoacetate is an alkylating reagent that modify thiol groups in 4 proteins by S-carboxymethilation (45); selenite is also known to catalyze the oxidation of 5 thiol groups and to induce protein aggregation (46); clioquinol, as a Cu ionophore, can 6 deliver metal ions into cells, where it exerts its activity through the interaction with thiol and 7 amino groups (47); finally, the previously identified vitamin K 3 (menadione) also contributes 8 to redox cycling and has alkylating properties, reacting as well with thiol groups (44). All of 9 these evidences suggest that the smeVWX induction mechanism might be related, at least in 10 part, to the thiol-reactivity of the inducer compounds. 11
In the case of the SmeYZ efflux pump, boric acid, erythromycin, chloramphenicol and 12 lincomycin were identified as inducers. Erythromycin, a macrolide antibiotic, targets the 50S 13 subunit of the bacterial ribosome and inhibits the nascent chain elongation (48). 14 Chloramphenicol is another antibiotic whose target is the 50S subunit of the ribosome by its 15 binding to the peptidyl-transferase center (PTC), where peptide-bond formations happen (49). 16
Both erythromycin and chloramphenicol are also known to directly inhibit the 50S subunit 17 biogenesis (50). The third identified antibiotic inducer, lincomycin, a lincosamide family 18 antibiotic, also targets the 50S subunit of the ribosome by inhibiting the peptide-bond 19 formation, as chloramphenicol (51). smeYZ was also found to be induced by boric acid, 20 which is not an antibiotic but impairs the acylation of tRNAs and inhibits protein synthesis 21 (52). All of these compounds share a common mechanism of action, suggesting that SmeYZ 22 mechanism of induction might be related to protein synthesis inhibition. Supporting this 23 possibility, other compounds from Biolog plates, such as oleandomycin, spiramycin, tylosin, 24 penimepiclyne or fusidic acid, whose mechanism of action is also protein synthesis 25 16 inhibition, were found to increase the YFP levels given by the PBT10 reporter strain (Table  1 2). These data reinforce the hypothesis that ribosome-stalling stress could be a signal that 2 triggers smeYZ expression. It has been previously reported that ribosome-targeting antibiotics 3 are able to induce the expression of the Pseudomonas aeruginosa MexXY efflux pump 4 through the induction of the expression of the PA5471 gene (53). In our case, it is possible 5 that SmeYZ plays a role in exporting anomalous peptides or processed by-products 6 alleviating ribosome-stalling stress. Notwithstanding these evidences, the molecular basis 7 underlying the mechanism remain to be established. 8
It has been described that RND efflux pumps extrude several of their known inducers, such as 9 aminoglycosides by MexXY-OprM in P. aeruginosa (54), or triclosan by SmeDEF in S. 10 maltophilia (33). The extrusion of the inducer molecules would be a protection mechanism 11 against these toxic agents. However, in this work we have described that the lack of either 12 SmeVWX and SmeYZ does not affect S. maltophilia growth from the action of their toxic 13 inducers ( Figure 5 ). Different circumstances have been proposed to explain this apparent 14 contradiction: one possibility is that the concentration for induction is lower or similar to the 15 toxic concentration of the tested compound, not allowing to detect an effect (26). Also, the 16 bacterium can contain more efficient mechanism, (e. g. other efflux pumps) able to extrude or 17 detoxify the same compounds, needing to be removed for the observation of an effect in the 18 bacterial growth (55). The possibility that an effector is not extruded by the efflux pump it 19 induces cannot be disregarded. In this respect, it is worth to notice that both RND substrates 20 and inducers of a given efflux pump are frequently structurally very diverse (39), although 21 they can interfere with the same cell machinery or target. Indeed, we have identified in this 22 work two common mechanisms of stress generated by a set of RND inducers, each one 23 inducing the expression of an efflux pump. It is important to consider that RND efflux pumps 24 mainly extrude substrates that are located in the periplasm (56), while the regulation of these 25 systems take place in the cytoplasm (57). This differentiated compartmentalization may 1 justify the possibility that RND inducers might not always be substrates of efflux pumps. 2 This means that in some situations, MDR efflux pumps might be overexpressed despite there 3 is no apparent advantage for the bacteria. However, the presence of the inducer may imply a 4 situation of transient resistance to other toxic compounds which represents a benefit in some 5 conditions. We have assessed this situation for clinically used antibiotics that are RND efflux 6 pumps substrates using sodium selenite and lincomycin, the strongest inducers of SmeVWX 7 and SmeYZ efflux pumps, respectively. Both inducer molecules were able to promote 8 transient reduced susceptibility to ofloxacin (SmeVWX substrate) or amikacin (SmeYZ 9 substrate). 10 This is a fact to take into account regarding clinical situations, since some of these inducer 11 molecules could be provided during a S. maltophilia infection treatment. For instance, 12 sodium selenite has been recently administered during a phase I clinical trial in terminal 13 cancer patients (58) due to its cytotoxic effect on proliferating cancer cells. Since these 14 patients are delicately vulnerable to infections caused by MDR Gram-negative bacteria, such 15 as S. maltophilia (59), the dispensation of sodium selenite could lead to the overexpression of 16 smeVWX and thus, transient resistance to its substrates. The clinical consequences of this 17 situation need to be further investigated. 18
Conclusions 19
Through the combination of Biolog phenotype microarrays and fluorescence-based reporter 20 strains, we have developed a new high-throughput methodology to identify MDR efflux 21 pumps inducer compounds. The common mechanism of action of the detected inducer 22 molecules has allowed us to establish possible mechanisms of induction of both smeVWX and 23 smeYZ in S. maltophilia. smeVWX is likely induced by those compounds related to thiol-24 18 reactivity, while smeYZ is induced by those agents that target the ribosome, suggesting a 1 relationship between the expression of the efflux pump and the inhibition of protein 2 synthesis. These results indicate that MDR efflux pump expression is not always triggered by 3 a specific compound, but by stress signals generated by certain molecules with the same 4 mechanism of action. 5
The knowledge of these environmental circumstances and/or the inducer molecules, is of 6 importance in terms of finding these agents in vivo, where they could compromise an 7 antibiotic therapy due to the induction of MDR efflux pumps (40). In our work, we have 8 determined that the presence of sodium selenite provides with ofloxacin resistance due to the 9 presence of SmeVWX; also, lincomycin is able to lead to amikacin resistance because of the 10 overexpression of smeYZ. 11
Materials and Methods 12
Bacterial strains and growth conditions 13
All plasmids and strains derived from this study are listed in Table 1 . All experiments were 14 performed using LB medium at 37 °C. The following antibiotics were added when required: 15 streptomycin (Sm; 50 µg/ml) for E. coli harboring the pSEVA4413 plasmid, ampicillin (Ap; 16 100 µg/ml) for E. coli containing the pGEM-T Easy vector and the pGEM-T-derived 17 plasmids pPBT02 and pPBT11, and kanamycin (Km; 50 µg/ml and 500 µg/ml) for E. coli 18 and S. maltophilia, respectively, for the selection of pSEVA237Y and the derived plasmids 19 pPBT04, pPBT05 and pPBT08. Medium was supplemented with 0.5 mM isopropyl-β-D-20 thiogalactopyranoside (IPTG) and 80 µg/ml 5-bromo-4-chloro-3-indolyl-β-D-21 galactopyranoside (X-Gal) for the induction and detection of β-galactosidase production. 22
Plasmid constructions 23 19
The PBT10 strain, which harbors the reporter plasmid pPBT08 containing the smeYZ 1 promoter region, was obtained as described previously (30) using the primers SmeYZ_F (5'-2 GAATTCGGCGGGGCCGTAAG-3', EcoRI site underlined) and SmeYZ_R (5'-3 AAGCTTTGCTGTGCACAATG-3', HindIII site underlined). In order to obtain the PBT03 4 strain, which harbors the pPBT05 plasmid with the constitutive promoter EM7, pSEVA4413 5 plasmid was digested with PacI and HindIII restriction enzymes (New England BioLabs). 6
The product corresponding to the EM7 promoter was purified from a 1 % agarose gel using a 7 DNA purification kit (GE Healthcare) and cloned into pSEVA237Y plasmid, previously 8 digested with the same restriction enzymes, using T4 DNA ligase (New England BioLabs). 9
The resulting plasmid pPBT05 was introduced by transformation in E. coli CC118λpir. Then, 10 pPBT05 was introduced into S. maltophilia D457 by tripartite matting as previously 11 described (30). 12
Deletion of smeZ 13
A partial deletion of the smeZ gene was performed in S. maltophilia D457 through 14 homologous recombination. 545-bp (ZA) and a 549-bp (ZB) fragments from the 5' end and 15 3' end of the smeZ gene, respectively, were amplified by PCR using primers ZAF (5'-16 GAATTCATGGCACGTTTCTTCATCGATCGCCCGGTGTTCGC-3', EcoRI site 17 underlined) and ZAR (5'-18 ATCGACAACAACAGCAGCCATGCTCGGCACCGAACAACTG-3'), and ZBF (5'-19 CAGTTGTTCGGTGCCGAGCATGGCTGCTGTTGTTGTCGAT-3') and ZBR (5'-20 GAATTCTCAACGATGTTCCGTTCCATCCACGGTTCCTCCCGGC-3', EcoRI site 21 underlined). An overlapping PCR was performed using ZA and ZB fragments as template 22 using ZAF and ZBR primers, obtaining a 1000-bp fragment (ZAB). This ZAB fragment was 23 purified from a 1 % agarose gel using a DNA purification kit (GE Healthcare) and cloned 24 into pGEM-T Easy (Promega) following the manufacturer's protocol. The sequence was 25 20 confirmed by DNA sequencing. Afterwards, this plasmid was digested using EcoRI (New 1 England BioLabs) and the resulting ZAB fragment was cloned into the suicide vector 2 pEX18Tc (60), obtaining the pZAB7 plasmid, which was introduced by transformation into 3 CC118λpir. Selection was performed using tetracycline (4 µg/ml). pZAB7 was introduced by 4 tripartite matting into S. maltophilia D457 (61) and selection was performed on LB agar 5 plates with tetracycline (12 µg/ml) and imipenem (20 µg/ml). Tet R colonies were streaked 6 onto 12 µg/ml tetracycline plates and 10 % sucrose plates. Tet R and Sac S colonies were 7 streaked onto 10 % sucrose plates and incubated at 30 °C overnight. From the sucrose plates, 8 Sac R colonies were streaked onto 12 µg/ml tetracycline plates and 10 % sucrose in order to 9 obtain double recombinants with the partial deletion of smeZ gene. Deletion was confirmed in 10 the PBT100 strain using primers FragZAB_L (5'-GTGCAGAACCGGATCAAG-3') and 11 FragZAB_R (5'-CGAACTCGACAATGAGGAT-3'), and InternoSmeZ_F (5'-12 CGGTGTCGATCCTGTTCT-3') and InternoSmeZ_R (5'-13 TGGATCGAGGTCATGAAATA-3'). 14
Biolog phenotype microarray assay 15
The phenotypic microarray experiment was performed using the 96-well plates PM11-16 16 from the Biolog Phenotypic Microarray (PM) System (Biolog), which contain a variety of 17 chemical agents including antimicrobials (62). All tested compounds are listed in Table S1 . 18
Each compound is found in four different quantities in the plates. To carry out the 19 experiment, 100 µl of LB medium were added to each well and plates were incubated at room 20 temperature under constant shaking for 2 h. The purpose of this first shaking incubation is to 21 dissolve the different compounds in the medium before inoculating the bacterial cells, since 22 the different chemical agents are dried to the base of each well. Ten microliters of an 23 overnight cell culture were added to each well to a final OD 600 of 0.01. Plates were then 24 incubated at 37 °C for 20 h using a Tecan Spark 10M plate reader (Tecan), measuring growth 25 21 (OD 600 ) and fluorescence every 10 min. Plates were shaken for 5 s every 10 min before each 1 measurement. For yellow fluorescent protein (YFP) detection, the plate reader was set with 2 an excitation wavelength at 508 nm and emission wavelength at 540 nm. 3
Normalization of the results 4
The analysis of the promoter activity for each reporter strain was performed following a two-5 step method. First, fluorescence curves were fitted to a first order differential equation, 6
analogously to the one that represents bacterial growth. In this way, the maximum specific 7 rate of fluorescence production (µ) was calculated according to the equation F (t) = F 0 e µ t 8 [being F (t): fluorescence across the time; F 0 : initial fluorescence; µ: maximum specific rate 9 of fluorescence production (h -1 ) and t: time (h)]. The parameter was obtained for the EM7 10 (µ EM7 ), smeYZ (µ YZ ) and smeVWX (µ VWX ) promoters for each specific compound and 11 concentration. Secondly, a normalization process was done with the µ YZ and µ VWX by dividing 12 them by the value of µ EM7 for each compound and concentration. We stablished a threshold of 13 1.5 x IQR (interquartile range) of each data set including all the compounds and 14 concentrations where detectable growth was observed to define overexpression. 15
Confirmation of the induction of gene expression 16
Sodium selenite, clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) and iodoacetate were 17 selected as possible inducers of the SmeVWX efflux pump, while boric acid and the 18 antibiotics erythromycin, chloramphenicol and lincomycin were chosen as possible inducers 19 of the SmeYZ efflux pump. First, minimum inhibitory concentration (MIC) was determined 20 for each compound by the microdilution method in LB using 96-well plates (NUNCLON TM ∆ 21 Surface). Ten microliters of an overnight cell culture were added to 140 µl of medium 22 containing different concentrations of the selected compound to a final OD 600 of 0.01. Plates 23 22 were incubated at 37 °C for 20 h without shaking. MIC value was defined by the lowest 1 concentration at which bacterial growth was not observed in the tested compound. 2 Three concentrations of each compound were chosen for the induction assay considering the 3 obtained MIC values: sodium selenite (0.25, 0.5, and 1 mM), clioquinol (78, 156, and 312 4 µM), iodoacetate (0.25, 0.5, and 1 mM), boric acid (3.125, 6.25, and 12.5 mM), erythromycin 5 (4, 8, and 16 µg/ml), chloramphenicol (0.5, 1, and 2 µg/ml) and lincomycin (64, 128, and 256 6 µg/ml). Ten microliters of the bacterial culture were added to 140 µl of medium to a final 7 OD 600 of 0.01 using Corning Costar 96-well black clear-bottom plates (Corning 8 Incorporated). Plates were incubated at 37 °C for 20 h, and growth (OD 600 ) and fluorescence 9 were monitored every 10 min in the plate reader Tecan Spark 10M (Tecan). Plates were 10 shaken for 5 s every 10 min before each measurement. An excitation wavelength at 508 nm 11 and emission wavelength at 540 nm were set for YFP detection. 12
Flow cytometry assays 13
S. maltophilia reporter strains PBT02 (P VWX ), PBT03 (P EM7 ) and PBT10 (P YZ ) were 14 inoculated in 100 ml Erlenmeyer flasks with 20 ml of LB medium to a final OD 600 of 0.01 15 and incubated at 37 °C with shaking. When bacterial cultures reached mid-exponential 16 growth phase (OD 600 ≈ 0.6), induction with the different compounds was performed using the 17 following concentrations: 0.5 mM sodium selenite, 78 µM clioquinol, 0.5 mM iodoacetate, 18 6.25 mM boric acid, 8 µg/ml erythromycin, 1 µg/ml chloramphenicol, and 128 µg/ml 19 lincomycin. A bacterial culture with no compound was used as control. Cells were then 20 incubated with shaking for 90 min at 37 °C. One milliliter of each culture was centrifuged at 21 13.000 rpm for 1 min at room temperature. Cells were washed with 500 µl of PBS and 22 centrifuged as indicated above. The bacterial pellets were suspended with 300 µl of 0.4 % 23 paraformaldehyde and incubated at room temperature for 10 min. Cells were then centrifuged 24 as above indicated and suspended in 1 ml of PBS. In order to avoid false positive signals, all 25 23 the media and buffers employed were filtered through 0.22 µm pore filters (Corning 1 Incorporated). With the aim of measuring YFP production at the single-cell level, samples of 2 each reporter strain containing 20.000 cells were analyzed using the Gallios TM flow cytometer 3 (Beckman Coulter). Data processing was accomplished with Kaluza 1.5 software (Beckman 4 Coulter). 5
RNA preparation and real-time RT-PCR 6
RNA was obtained as described previously with some modifications (30). Briefly, a 100 ml 7
Erlenmeyer flask with 20 ml of LB medium was inoculated with an overnight culture of S. 8 maltophilia D457 to reach a final OD 600 of 0.01. Cell cultures were incubated at 37 °C in 9 agitation until they reached mid-exponential growth phase (OD 600 ≈ 0.6). At this point, the 10 induction assay was performed adding the different compounds at the concentrations 11 required: 0.5 mM sodium selenite, 78 µM clioquinol, 0.5 mM iodoacetate, 6.25 mM boric 12 acid, 8 µg/ml erythromycin, 1 µg/ml chloramphenicol, and 128 µg/ml lincomycin. A 13 bacterial culture with no compound was used as control. Cultures were incubated with 14 shaking for 90 min. Ten milliliters of each culture were taken and centrifuged at 8.000 rpm 15 for 20 min at 4 °C. RNA extraction was performed as described (30) Relative changes in gene expression were determined according to the 2 -∆∆CT method (63). 1 Mean values were obtained from three independent replicates in each experiment. 2
Determination of transient resistance to antibiotics 3
In order to determine the contribution of SmeVWX and SmeYZ to transient resistance to 4 antibiotics, the respective inducer molecules of each efflux pump, sodium selenite and 5 lincomycin, were selected to carry out growth curves in the presence of antibiotics. D457 and 6 MBS704 (DsmeW) strains were grown in ofloxacin (2 µg/ml), sodium selenite (0.5 mM), or 7 ofloxacin and sodium selenite in combination at the same concentrations. On its hand, D457 8 and PBT100 (DsmeZ) strains were grown in the presence of amikacin (16 µg/ml), lincomycin 9 (128 µg/ml), or amikacin and lincomycin in combination at the same concentrations. Ten 10 microliters of overnight cultures of the three S. maltophilia strains were added to 140 µl of 11 LB medium containing the different compounds to a final OD 600 of 0.01 in 96-well plates 12 (NUNCLON TM Delta Surface). Plates were incubated at 37 °C for 20 h using a Tecan Spark 13 10M plate reader (Tecan) and growth (OD 600 ) was recorded every 10 min. Plates were shaken 14 for 5 s before every measurement. 15 were also performed in the presence of amikacin (solid gray), lincomycin (solid light green) 6 and both amikacin and lincomycin (dotted green) in D457 (C) and PBT100 (ΔsmeZ) (D) 7 strains. Growth in LB medium is represented in solid dark blue lines for the three strains. 8
Error bars show the standard deviations derived from three independent replicates. SE, 9 sodium selenite; OFX, ofloxacin; LCM, lincomycin; AMK, amikacin. 
